Abstract
Activation of the nitric oxide-cGMP signaling pathway precedes resolution in acute anti-thy1 glomerulonephritis
Highlights
Yingrui Wang-Rosenke*, Stephanie Krämer, Tanja Loof, Sebastian Martini, Dmytro Khadzhynov, Eva Binder, Hans-Hellmut Neumayer and Harm Peters
3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here.
nitric oxide (NO)-cGMP signaling was characterized by measuring glomerular NO and cGMP production as well as glomerular mRNA expression of endothelial NO synthase, inducible NOS, alpha1 and beta1 soluble guanylate cyclase and phosphodiesterase-5 (PDE-5)
Summary
Yingrui Wang-Rosenke*, Stephanie Krämer, Tanja Loof, Sebastian Martini, Dmytro Khadzhynov, Eva Binder, Hans-Hellmut Neumayer and Harm Peters. Address: Charité Universitätsmedizin Berlin, Charité Campus Mitte, Department of Nephrology, Berlin, Germany. Published: 25 July 2007 BMC Pharmacology 2007, 7(Suppl 1):P63 doi:10.1186/1471-2210-7-S1-P63. 3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
